These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 310809)

  • 1. Why do protease inhibitors enhance leucocyte migration inhibition to the antigen PPD?
    Burden AC; Stacey R; Wood RF; Bell PR
    Immunology; 1978 Dec; 35(6):959-62. PubMed ID: 310809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of protease inhibitors on leucocyte migration inhibition to tuberculin extract (P.P.D.).
    Burden AC; Stacey RL; Wood RF; Bell PR
    Immunology; 1978 Feb; 34(2):217-21. PubMed ID: 304839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of E-amino caproic acid on macrohage cell coat and migration inhibtion.
    Hammond ME; Dvorak AM; Roblin RO; Morgan ES; Dvorak HF
    J Reticuloendothel Soc; 1978 Jul; 24(1):63-72. PubMed ID: 357720
    [No Abstract]   [Full Text] [Related]  

  • 4. Leucocyte migration inhibition factor (LIF) production by lymphocytes of normal children, newborns, and children with immune deficiency.
    Hahn T; Levin S; Handzel ZT
    Clin Exp Immunol; 1976 Jun; 24(3):448-54. PubMed ID: 133010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactoferrin stimulates the production of leucocyte migration inhibitory factor by human peripheral mononuclear leucocytes.
    Kijlstra A; Broersma L
    Clin Exp Immunol; 1984 Feb; 55(2):459-64. PubMed ID: 6365377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro production of leucocyte migration inhibitory factor by lymphocytes in exudative pleural effusions.
    Pettersson T; Welin MG; Weber TH
    J Clin Lab Immunol; 1982 Jun; 8(2):107-11. PubMed ID: 7050387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of cyclic AMP on leucocyte inhibitory factor (LIF) production and on the inhibition of leucocyte migration.
    Lomnitzer R; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1976 Apr; 24(1):42-8. PubMed ID: 181189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of C5 convertase by epsilon amino caproic acid (EACA): a limiting factor in the generation of C5a anaphylatoxin.
    Vallota EH
    Immunology; 1978 Mar; 34(3):439-47. PubMed ID: 417019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of migration inhibition tests in penicillin hypersensitivity.
    Warrington RJ; Sauder PJ; Rutherford WJ
    Clin Exp Immunol; 1979 Oct; 38(1):148-57. PubMed ID: 393437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of human lymphoid cell line lymphokine preparations (LCL-LK) as working standards in the bioassay of human leucocyte migration inhibition factor (LIF).
    Hamblin AS; Zawisza B; Shipton U; Dumonde DC; Den Hollander FC; Verheul H
    J Immunol Methods; 1982 Nov; 54(3):317-29. PubMed ID: 6757327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular hypersensitivity to tuberculin in BCG-revaccinated persons studied by skin reactivity, leucocyte migration inhibition and lymphocyte proliferation.
    Repo H; Kostiala AA; Kosunen TU
    Clin Exp Immunol; 1980 Feb; 39(2):442-8. PubMed ID: 6993072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucocyte migration inhibition assay from clotted plasma droplets.
    Welin MG; Mäkinen T; Weber TH
    J Clin Lab Immunol; 1982 May; 8(1):65-8. PubMed ID: 6808136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of a histamine-Sepharose-adherent subpopulation of human mononuclear cells in the production of leucocyte migration inhibition factor (LIF) in healthy children.
    Reichman BL; Handzel ZT; Segal S; Weinstein Y; Levin S
    Clin Exp Immunol; 1979 Sep; 37(3):562-6. PubMed ID: 389498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro inhibition of streptokinase-induced proteolysis by Trasylol and by epsilon amino caproic acid (EACA).
    Godal HC; Theodor I
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:199+. PubMed ID: 5295419
    [No Abstract]   [Full Text] [Related]  

  • 16. Conditions for generating and assaying human leukocyte inhibitory factor (LIF) induced by purified protein derivative (PPD).
    Maurer BA; Siwarski DF; Fischetti GP; McCoy JL; Dean JH; Herberman RB
    Immunopharmacology; 1978 Dec; 1(1):57-69. PubMed ID: 45790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leucocyte capillary migration: an adherence dependent phenomenon.
    Lomnitzer R; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1976 Aug; 25(2):303-10. PubMed ID: 182422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage of the third complement component (C3) and generation of the spasmogenic peptide, C3a, in human serum via the properdin pathway: demonstration of inhibitory as well as enhancing effects of epsilon-amino-caproic acid.
    Vogt W; Schmidt G; Lynen R; Dieminger L
    J Immunol; 1975 Feb; 114(2 Pt 1):671-7. PubMed ID: 804510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative effectiveness of epsilon-aminocaproic acid and contrical in preventing complement activation on immune complexes].
    Tsibul'kin AP; Raĭzman SM
    Farmakol Toksikol; 1981; 44(3):316-9. PubMed ID: 6169545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human transfer factor in vitro. II. Augmentation of the secretion of leucocyte migration inhibitory factor (LIF) by leucocyte dialysate and by its components L-serine and glycine.
    Ashorn RG; Räsänen L; Marnela KM; Krohn KJ
    Clin Exp Immunol; 1979 Jul; 37(1):50-7. PubMed ID: 385187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.